The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
COMy 2022 | Challenges faced when treating transplant-ineligible patients with myeloma
Mohamad Mohty, MD, PhD, Saint-Antoine Hospital, Paris, France, highlights some of the challenges faced by clinicians when treating older, transplant-ineligible patients with multiple myeloma. Dr Mohty mentions some of the issues in this area, including managing these patients and accurately assessing frailty, which will all be discussed by specialists at the 8th World Congress on Controversies in Multiple Myeloma (COMy), 2022.
